论文部分内容阅读
Astepro关键词:鼻喷雾剂美国FDA日前批准已上市的鼻喷雾剂Astelin的二代产品——Astepro的上市申请。Astepro较Astelin有所改进,而且病人对这种新的喷雾剂的耐受性更好。这类药物的活性成分是氮卓斯汀(azelastine),这是美国目前治疗鼻炎的主要抗组胺药物。
Astepro Keywords: nasal spray FDA recently approved the nascent spray nasal Astelin’s second generation products - Aspropro listing application. Astepro improves over Astelin, and patients are more tolerant of this new spray. The active ingredient in these drugs is azelastine, the main antihistamine in the United States currently used to treat rhinitis.